Fidia Farmaceutici S.P.A.
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 4 name spellings.
15
Ending by 2030
May 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 19, 2026The maintenance fee for Process for the synthesis of conjugates of glycosaminoglycanes (GAG) with biologically active molecules, polymeric conjugates and relative uses thereof (US 9,034,624) comes due Nov 19, 2026. Unpaid by May 19, 2027, it lapses early.
- 1 fee due Dec 27, 2026The maintenance fee for Multilayer composite material (US 11,684,588) comes due Dec 27, 2026. Unpaid by Jun 28, 2027, it lapses early.
- 1 fee due Jan 30, 2027The maintenance fee for Derivatives obtained from hyaluronic acid and carnosine (US 10,364,299) comes due Jan 30, 2027. Unpaid by Jul 30, 2027, it lapses early.
- 1 fee due Mar 3, 2027The maintenance fee for Bacterial hyaluronidase and process for its production (US 10,400,229) comes due Mar 3, 2027. Unpaid by Sep 3, 2027, it lapses early.
- 2 fees due Apr 8 to 20, 2027 · next Apr 8
- 1 fee due May 19, 2027The maintenance fee for Dermal therapeutic system with high adhesivity (US 10,478,413) comes due May 19, 2027. Unpaid by Nov 19, 2027, it lapses early.
- 2 fees due Aug 4 to 23, 2027 · next Aug 4
- 2 fees due Sep 15 to 22, 2027 · next Sep 15
Recent changes
- 1 of the patents on this record was granted since Aug 21, 2026
- Sep 1 US 12,721,862 Pharmaceutical Composition for Use in the Treatment of Cystitis of Various Etiologies
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,759,095 | Process for the preparation and isolation of phosphatides In force · USPTO record | In force | USPTO record | |
| US 7,863,256 | Amide derivatives of hyaluronic acid in osteoarthrosis In force · USPTO record | In force | USPTO record | |
| US 9,283,284 | Use of conjugates of hyaluronic acid in the local treatment of hyperproliferative skin diseases In force · USPTO record | In force | USPTO record | |
| US 9,687,558 | Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation, and their use in the pharmaceutical field In force · USPTO record | In force | USPTO record | |
| US 9,789,200 | Therapeutic use of new pharmaceutical preparations containing antitumoral drugs bound to hyaluronic acid in the treatment of neoplasias In force · USPTO record | In force | USPTO record | |
| US 8,633,169 | Antiviral topical formulations in the form of a bio-adhesive gel In force · USPTO record | In force | USPTO record | |
| US 8,900,576 | Pharmaceutical compositions containing hyaluronic acid and collagenase for the topical treatment of wounds, burns and ulcers In force · USPTO record | In force | USPTO record | |
| US 9,808,482 | Sulphated hyaluronic acids as regulator agents of the cytokine activity In force · USPTO record | In force | USPTO record | |
| US 10,548,918 | Sulphated hyaluronic acids as regulator agents of the cytokine activity In force · USPTO record | In force | USPTO record | |
| US 10,208,300 | Extracellular hyaluronidase from Streptomyces koganeiensis In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 57: 4 patents in force now held by others · 24 lapsed for an unpaid fee · 35 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
5 pending · 2 abandoned · 7 no status recorded